Antoine Fraissenon

7PUBLICATIONS
61CO-AUTHORS
Neurology and neuromuscular diseasesTerahertz physicsHypersonic propulsion and hypersonic aerothermodynamicsMedical infection agents (incl. prions)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2025
PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

Quitterie Venot, Marina Firpion, Sophia Ladraa

|Jun 06, 2025
First report of successful pregnancies after treatment with alpelisib for PIK3CA-related overgrowth spectrum.

Gabriel Morin, Antoine Fraissenon, Caroline Chopinet

|May 19, 2025
Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

Gabriel Morin, Alexandre P Garneau, Nabiha Bouzakher

|Sep 15, 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.

Charles Bayard, Eleonora Segna, Maxime Taverne

|Dec 09, 2022
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.

Sophia Ladraa, Lola Zerbib, Charles Bayard

|Jan 26, 2022
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.

Gabriel Morin, Caroline Degrugillier-Chopinet, Marie Vincent

Pageof 2

Frequent Collaborators

5 joint publications

Gabriel Morin

4 joint publications

Guillaume Canaud

3 joint publications

Patrick Villarese

3 joint publications

Jean-Paul Duong